So, in 2025, IBIT (BlackRock iShares Bitcoin Trust) is raking in almost all the Bitcoin ETF cash in the U.S., while other funds are losing money. Do institutions believe in IBIT, or are they overly trusting of a single fund?

Recent advancements in diabetes and Alzheimer's treatments have led to an increase in investment in LLY stocks. What is the projected growth trajectory of this company in the upcoming years? Are there any market trends that might affect their performance in the pharmaceutical sector? Is it profitable to invest in this company or not?